What happened: UK Health Secretary Steve Streeting said he feels 'uncomfortable' about puberty blockers but will continue the trial based on expert advice.
Why it matters:
- The decision affects transgender youth undergoing medical treatment in the UK.
- It highlights ongoing debates about the safety and ethics of puberty blockers.
MNN Take: The Health Secretary is balancing personal concerns with medical guidance, maintaining the trial to gather more evidence on puberty blockers' effects.
Sources: BBC UK